Enanta Pharmaceuticals (ENTA) Preferred Shares (2015 - 2016)

Enanta Pharmaceuticals (ENTA) reported Preferred Shares of $158000.0 for Q2 2016, up 1.28% quarter-over-quarter from $156000.0 in Q1 2016.

Enanta Pharmaceuticals (ENTA) Preferred Shares (2015 - 2016) Analysis & Trends

Enanta Pharmaceuticals has reported Preferred Shares for 2 years, with the latest figure at $158000.0 in Q2 2016.

For the quarter ending Q2 2016, Preferred Shares changed N/A year-over-year to $158000.0; the trailing twelve-month figure through Jun 2016 stood at $158000.0 (changed N/A YoY), and the FY2015 full-year result was $163000.0, changed N/A from the prior year.
Preferred Shares for Q2 2016 stood at $158000.0, up from $156000.0 in the prior quarter.
The five-year high for Preferred Shares was $163000.0 in Q3 2015, with the low at $156000.0 in Q1 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Enanta Pharmaceuticals	365.48 Mn	201.71 Mn	-	-

Download Data